N/A(healthy adults)
Conditions
Interventions
Oral intake of the test product (8g in a day
12 weeks)
Oral intake of the placebo product (8g in a day
Sponsors
TES Holdings Co., Ltd
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: [1]Females aged 30-59 years [2]Individuals who are healthy and have no chronic physical disease including skin disease [3]Individuals who are concerning on dry skin [4]Individuals whose written informed consent has been obtained [5]Individuals who can have an examination in a designated day [6]Individuals judged appropriate for the study by the principal
Exclusion criteria
Exclusion criteria: [1]Individuals using medical products [2]Individuals with skin disease, such as atopic dermatitis [3]Individuals with strange skin conditions at measurement points [4]Individuals who used or applied a drug for treatment of disease in the past 1 month [5]Individuals who have a history of serious hepatopathy, kidney damage, heart disease, hematological and blood disease [6]Individuals who contract or have a history of serious gastrointestinal disease [7]Individuals with serious anemia [8]Individuals who have milk allergy [9]Individuals who are sensitive to test product or other foods, and medical products [10]Individuals who are or are possibly pregnant, or are lactating [11]Individuals who have an addiction to alcohol or a mental illness [12]Individuals who are a smoker [13]Individuals with possible changes of life style, such as working a night shift or conducting a long-term travel, during the test period [14]Individuals with probable seasonal allergy, such as pollinosis, during the test period [15]Individuals who are busy to their own work, housework or child care and neglect skin care [16]Individuals who cannot avoid daylight exposure during the test period [17]Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period [18]Individuals who have a habit to use drug claiming to improve skin condition in the past 3 months [19]Individuals who had been conducted an operation on the test spot [20]Individuals who had been conducted an operation on the test spot [21]Individuals who participated in other clinical studies in the past 3 months [22]Individuals judged inappropriate for the study by the principal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| [1]Skin moisture content (Week 0, Week 6, Week 12) | — |
Secondary
| Measure | Time frame |
|---|---|
| *Secondary outcomes [1]Transepidermal water loss (Week 0, Week 6, Week 12) [2]Colour difference (Week 0, Week 6, Week 12) [3]Observation for skin condition by a specialist (Week 0, Week 6, Week 12) [4]Anti-Aging QOL Common Questionnaire (Week 0, Week 6, Week 12) [5]Profile of Mood States Japanese Version (Week 0, Week 6, Week 12) [6]Visual Analogue Scale (Week 0, Week 6, Week 12) *Safety [1]Diagnosis by doctors (Week 0, Week 6, Week 12) *Other outcomes [1]Subject's diary(From the first day of ingestion of a test material to the last day of the test) | — |
Countries
Japan
Contacts
Public ContactToshiyasu Tamura
TES Holdings Co., Ltd Department of Development for Clinical Trials
Outcome results
None listed